REGENXBIO Inc.

RGNX · Nasdaq · SIC 2836: Biological Products, (No Diagnostic Substances) · Market Cap: $0.4B · 371 employees
182
SEC Filings
$7.01
Close 2026-05-29
371
Employees

Business Summary

2 Item 1A. Risk Factors 33 Item 1B. Unresolved Staff Comments 69 Item 1C. Cybersecurity 69 Item 2. Properties 70 Item 3. Legal Proceedings 70 Item 4. Mine Safety Disclosures 70 Part II Item 5. Market for Registrants Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 71 Item 6. Reserved 71 Item 7. Managements Discussion and Analysis of Financial Condition and Results of Operations 72 Item 7A. Quantitative and Qualitative Disclosures about Market Risk 88 Item 8. F...

Latest Stock Quote

RGNX 2026-05-29 $7.01 O:$7.04 H:$7.0886 L:$6.82 Vol:1.1M VWAP:$6.9615
origin leaf: c9313a880b79ab8112c844ba74083484f6687d29038e13251b4c55e1340ab962

Next Earnings

Q2 FY2026 — expected 2026-08-15

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-052025-12-310001193125-26-094013EDGAR108K words
2025-03-132024-12-310000950170-25-038770EDGAR
2024-02-272023-12-310000950170-24-021161EDGAR
2023-02-282022-12-310000950170-23-005085EDGAR
2022-03-012021-12-310001564590-22-008055EDGAR
2021-03-012020-12-310001564590-21-009855EDGAR
2020-02-262019-12-310001564590-20-006826EDGAR
2019-02-272018-12-310001564590-19-004920EDGAR
2018-03-062017-12-310001564590-18-004532EDGAR
2017-03-072016-12-310001564590-17-003576EDGAR

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-062025-09-300001193125-25-268095EDGAR37K words
2025-08-072025-06-300001193125-25-174953EDGAR
2025-05-122025-03-310000950170-25-069237EDGAR
2024-11-062024-09-300000950170-24-122330EDGAR
2024-08-012024-06-300000950170-24-089320EDGAR
2024-05-082024-03-310000950170-24-055691EDGAR
2023-11-082023-09-300000950170-23-061144EDGAR
2023-08-022023-06-300000950170-23-037178EDGAR
2023-05-032023-03-310000950170-23-017200EDGAR
2022-11-032022-09-300000950170-22-021567EDGAR
2022-08-032022-06-300001564590-22-027764EDGAR
2022-05-042022-03-310001564590-22-017878EDGAR

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-200001193125-26-117913EDGAR1K words
2026-03-050001193125-26-092566EDGAR
2026-02-100001193125-26-043342EDGAR
2026-01-280001193125-26-026139EDGAR
2025-11-060001193125-25-268101EDGAR
2025-08-180000950170-25-109829EDGAR
2025-08-070001193125-25-174947EDGAR
2025-06-030000950170-25-080986EDGAR
2025-05-190001193125-25-122456EDGAR
2025-05-120000950170-25-069211EDGAR

182 total filings indexed. 150 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

FDMT — 4D Molecular Therapeutics, Inc. APTN — ADAPTIN BIO, INC. ADMA — ADMA BIOLOGICS, INC. AGEN — AGENUS INC AIM — AIM ImmunoTech Inc. AMGN — AMGEN INC AVXL — ANAVEX LIFE SCIENCES CORP. ABPO — Abpro Holdings, Inc.

Company Identity

CIK0001590877
TickerRGNX
ExchangeNasdaq
SIC2836: Biological Products, (No Diagnostic Substances)
Websitehttps://www.regenxbio.com
Listed2015-09-17

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 858e5e375c372edc04aac4e7bae20984075d380357f246596106b4bbc6c95502
parent: c3a4db5b1fba0f0c9e71923ff024221253a4fff7d766ae40de9eefbeb57a15e8
content hash: 679bc2f6cc1f8d753ba6e1cfb9af639c336fa4adc5a1b55222710c6a690a69be
signed: 2026-06-03T12:02:25.070Z
sources: 23 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf